Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics
- PMID: 22403552
- PMCID: PMC3289044
- DOI: 10.3389/fpsyt.2012.00011
Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics
Abstract
This study explored the affect expression and self-regulation capacities of 8-month-old infants exposed in utero to psychotropic medications. This was a continuation of our previous study conducted on the same cohort when the infants were 3 months old. Psychotropics implicated included selective serotonin reuptake inhibitors (SSRIs), and a benzodiazepine derivative anxiolytic (clonazepam). The three comparison groups were: control (n = 23; infants not exposed to psychotropics in utero), SSRI-alone (n = 22; infants exposed to SSRIs only and having mothers who had a primary diagnosis of depressive disorder without having comorbid anxiety disorder), and SSRI+ group (n = 15; infants gestationally exposed to SSRIs and clonazepam and having mothers that had both clinical depression and anxiety disorder). Using the Parent-Child Early Relational Assessment Scale, infants were assessed in a dyadic context during free play and a structured task. There were significant differences in psychotropic exposed and non-exposed dyads regarding infant negative affect management. There were significant associations between the SSRI+ group of mothers and infant negative affect. This group of mothers also showed significant associations with infants' averting and avoiding behaviors in both play situations. The SSRI-alone group was similar to the control group and showed variable associations with infant's positive, negative, and sober moods unlike the SSRI+ group. There were no differences in infants' capacity for self-regulation in psychotropic exposed and non-exposed groups. Increased awareness of these vulnerable subgroups (SSRI-alone and SSRI+) is needed, in order to safeguard these dyads through better support systems and improved management.
Keywords: affect expression; gestational exposure; infants; psychotropics; self-regulation.
References
-
- Bakker M. K., Kolling P., Van Den Berg P. B., De Walle H. E., De Jong Van Den Berg L. T. (2008). Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br. J. Clin. Pharmacol. 65, 600–60610.1111/j.1365-2125.2007.03048.x - DOI - PMC - PubMed
-
- Bayley N. (1993). Bayley Scales of Infant Development. Second Edn. San Antonio: The Psychological Corportation
LinkOut - more resources
Full Text Sources
